Dexamfetamine for adults with ADHD and depression
Part of Mental health clinical trials.
This trial tests a study medication (dexamfetamine) for adults who have both ADHD and moderate to severe depression. It aims to see if the medication is safe and helps improve both conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 65 years old
- You must have been diagnosed with ADHD since childhood (before age 12)
- You must have moderate to severe depression that is not controlled by current treatment
- You must be currently taking a stable dose of certain antidepressants (SSRIs or SNRIs) for at least 2 weeks
- You must be willing to stop any current ADHD medications during the study
- You cannot have serious heart problems, a history of seizures, or certain other medical conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a mixed amphetamine medication helps teenagers with both autism and ADHD who still have significant symptoms, even if they are already on other treatments. It also includes typically developing teens as a comparison group.
This trial tests an experimental drug (EB-1020) for children with ADHD. It aims to see if the drug is safe and effective in reducing ADHD symptoms.
This trial tests a new medication called EB-1020 for adults with ADHD. It aims to see if the drug is safe and effective in improving ADHD symptoms. You may be able to join if you have a clear ADHD diagnosis and your symptoms are moderate to severe.
This trial tests a new medication added to your current treatment for chronic depression that hasn't gotten better with at least two antidepressants and 12 therapy sessions. It might help when standard treatments aren't enough.
This study tests a combination medication (dextromethorphan plus bupropion) to see how it affects brain activity in people with moderate-to-severe depression. Researchers use brain imaging (fMRI) to understand how the drug works and whether it may help relieve depression symptoms.
This study tests a new combination of two medications (dextromethorphan and bupropion) as a treatment for major depressive disorder. It may be an option if you have not already tried many antidepressants that didn't work.
Hear when a new Depression - Major Depressive Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.